The U.S. pharmaceutical supply chain faces a threat equal to the rare-earths challenge already posed by China’s exploitation of its dominance of those critical minerals. The authors provide a model th...
A new report by @cfr.org @tombollyky.bsky.social @rushdoshi.bsky.social @prof-yadav.bsky.social , Olivia Kosloff & Elena Every on the risks of China weaponizing pharma supply chains as a tool of economic or political coercion.
www.cfr.org/reports/the-...
